Consumer products company Colgate-Palmolive (NYSE:CL) will be reporting results tomorrow before market open. Here’s what investors should know.
Colgate-Palmolive met analysts’ revenue expectations last quarter, reporting revenues of $5.03 billion, up 2.4% year on year. It was a mixed quarter for the company, with a decent beat of analysts’ organic revenue estimates but a slight miss of analysts’ EBITDA estimates.
Is Colgate-Palmolive a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Colgate-Palmolive’s revenue to be flat year on year at $4.98 billion, slowing from the 6.9% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.89 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Colgate-Palmolive has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 1.7% on average.
Looking at Colgate-Palmolive’s peers in the household products segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Procter & Gamble delivered year-on-year revenue growth of 2.1%, beating analysts’ expectations by 1.3%, and WD-40 reported revenues up 9.3%, topping estimates by 4.1%. Procter & Gamble traded up 2.8% following the results while WD-40 was down 5.8%.
Read our full analysis of Procter & Gamble’s results here and WD-40’s results here.
Stocks generally had a good 2024. The Fed fought high inflation and won without sending the economy into a recession, otherwise lovingly known as a soft landing. The US Central Band is now cutting rates. That, plus the election of Donald Trump in November 2024, sent markets even higher, and while some of the household products stocks have shown solid performance, the group has generally underpeformed, with share prices down 2.9% on average over the last month. Colgate-Palmolive is down 1% during the same time and is heading into earnings with an average analyst price target of $100.87 (compared to the current share price of $89.57).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.